Putting the onus on the existing medications and treatments used pre and in ICU - what price do you put on the time expended and also the failure of the existing treatments to save lives. This is where pharmaeconomics comes in, where a price is routinely put on life and medications, outside of triage.
What you might like to believe is expensive can in fact provide a cost saving or other highly prized benefit for national health systems and insurers.
MSB Trading 2021 - paradigm shift, page-111
-
- There are more pages in this discussion • 10,100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.028(1.85%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $15.87M | 10.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 68278 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 20003 | 18 |
View Market Depth
| Last trade - 15.07pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |